196 related articles for article (PubMed ID: 7540887)
1. Purified CD34+ Lin- Thy+ stem cells do not contain clonal myeloma cells.
Gazitt Y; Reading CC; Hoffman R; Wickrema A; Vesole DH; Jagannath S; Condino J; Lee B; Barlogie B; Tricot G
Blood; 1995 Jul; 86(1):381-9. PubMed ID: 7540887
[TBL] [Abstract][Full Text] [Related]
2. Differential mobilization of myeloma cells and normal hematopoietic stem cells in multiple myeloma after treatment with cyclophosphamide and granulocyte-macrophage colony-stimulating factor.
Gazitt Y; Tian E; Barlogie B; Reading CL; Vesole DH; Jagannath S; Schnell J; Hoffman R; Tricot G
Blood; 1996 Jan; 87(2):805-11. PubMed ID: 8555506
[TBL] [Abstract][Full Text] [Related]
3. Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of multiple myeloma patients: positive selection and transplantation of enriched CD34+ cells to remove circulating tumor cells.
Lemoli RM; Fortuna A; Motta MR; Rizzi S; Giudice V; Nannetti A; Martinelli G; Cavo M; Amabile M; Mangianti S; Fogli M; Conte R; Tura S
Blood; 1996 Feb; 87(4):1625-34. PubMed ID: 8608257
[TBL] [Abstract][Full Text] [Related]
4. Transplantation with selected autologous peripheral blood CD34+Thy1+ hematopoietic stem cells (HSCs) in multiple myeloma: impact of HSC dose on engraftment, safety, and immune reconstitution.
Michallet M; Philip T; Philip I; Godinot H; Sebban C; Salles G; Thiebaut A; Biron P; Lopez F; Mazars P; Roubi N; Leemhuis T; Hanania E; Reading C; Fine G; Atkinson K; Juttner C; Coiffier B; Fière D; Archimbaud E
Exp Hematol; 2000 Jul; 28(7):858-70. PubMed ID: 10907648
[TBL] [Abstract][Full Text] [Related]
5. Transplantation of CD34+ peripheral blood progenitor cells after high-dose chemotherapy for patients with advanced multiple myeloma.
Schiller G; Vescio R; Freytes C; Spitzer G; Sahebi F; Lee M; Wu CH; Cao J; Lee JC; Hong CH
Blood; 1995 Jul; 86(1):390-7. PubMed ID: 7540888
[TBL] [Abstract][Full Text] [Related]
6. Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of patients with multiple myeloma.
Lemoli RM; Cavo M; Fortuna A
J Hematother; 1996 Aug; 5(4):339-49. PubMed ID: 8877709
[TBL] [Abstract][Full Text] [Related]
7. Peripheral blood CD34+ cells differ from bone marrow CD34+ cells in Thy-1 expression and cell cycle status in nonhuman primates mobilized or not mobilized with granulocyte colony-stimulating factor and/or stem cell factor.
Donahue RE; Kirby MR; Metzger ME; Agricola BA; Sellers SE; Cullis HM
Blood; 1996 Feb; 87(4):1644-53. PubMed ID: 8608259
[TBL] [Abstract][Full Text] [Related]
8. Enrichment of human hematopoietic stem cell activity in the CD34+Thy-1+Lin- subpopulation from mobilized peripheral blood.
Murray L; Chen B; Galy A; Chen S; Tushinski R; Uchida N; Negrin R; Tricot G; Jagannath S; Vesole D
Blood; 1995 Jan; 85(2):368-78. PubMed ID: 7529060
[TBL] [Abstract][Full Text] [Related]
9. BCR-ABL expression in different subpopulations of functionally characterized Ph+ CD34+ cells from patients with chronic myeloid leukemia.
Maguer-Satta V; Petzer AL; Eaves AC; Eaves CJ
Blood; 1996 Sep; 88(5):1796-804. PubMed ID: 8781437
[TBL] [Abstract][Full Text] [Related]
10. Cytogenetically aberrant cells in the stem cell compartment (CD34+lin-) in acute myeloid leukemia.
Mehrotra B; George TI; Kavanau K; Avet-Loiseau H; Moore D; Willman CL; Slovak ML; Atwater S; Head DR; Pallavicini MG
Blood; 1995 Aug; 86(3):1139-47. PubMed ID: 7542497
[TBL] [Abstract][Full Text] [Related]
11. A comparative study of the phenotype and proliferative capacity of peripheral blood (PB) CD34+ cells mobilized by four different protocols and those of steady-phase PB and bone marrow CD34+ cells.
To LB; Haylock DN; Dowse T; Simmons PJ; Trimboli S; Ashman LK; Juttner CA
Blood; 1994 Nov; 84(9):2930-9. PubMed ID: 7524760
[TBL] [Abstract][Full Text] [Related]
12. Peripheral blood harvest of unaffected CD34+ CD38- hematopoietic precursors in paroxysmal nocturnal hemoglobinuria.
Prince GM; Nguyen M; Lazarus HM; Brodsky RA; Terstappen LW; Medof ME
Blood; 1995 Nov; 86(9):3381-6. PubMed ID: 7579441
[TBL] [Abstract][Full Text] [Related]
13. Collection, tumor contamination, and engraftment kinetics of highly purified hematopoietic progenitor cells to support high dose therapy in multiple myeloma.
Tricot G; Gazitt Y; Leemhuis T; Jagannath S; Desikan KR; Siegel D; Fassas A; Tindle S; Nelson J; Juttner C; Tsukamoto A; Hallagan J; Atkinson K; Reading C; Hoffman R; Barlogie B
Blood; 1998 Jun; 91(12):4489-95. PubMed ID: 9616143
[TBL] [Abstract][Full Text] [Related]
14. CD34+Thy-1+Lin- stem cells from mobilized peripheral blood.
Murray LJ; Tsukamoto A; Hoffman R
Leuk Lymphoma; 1996 Jun; 22(1-2):37-42, follow. 186, color plate I. PubMed ID: 8724526
[TBL] [Abstract][Full Text] [Related]
15. Delineation of T-progenitor cell activity within the CD34+ compartment of adult bone marrow.
Galy AH; Cen D; Travis M; Chen S; Chen BP
Blood; 1995 May; 85(10):2770-8. PubMed ID: 7537981
[TBL] [Abstract][Full Text] [Related]
16. Plasma cells composing plasmacytoma have phenotypes different from those of myeloma cells.
Sakai A; Fujii T; Noda M; Hyodo H; Oda K; Kimura A
Am J Hematol; 1996 Dec; 53(4):251-3. PubMed ID: 8948665
[TBL] [Abstract][Full Text] [Related]
17. Characterization of CD34+ peripheral blood cells from healthy adults mobilized by recombinant human granulocyte colony-stimulating factor.
Tjønnfjord GE; Steen R; Evensen SA; Thorsby E; Egeland T
Blood; 1994 Oct; 84(8):2795-801. PubMed ID: 7522643
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic and functional characterization of long-term culture-initiating cells present in peripheral blood progenitor collections of normal donors treated with granulocyte colony-stimulating factor.
Prosper F; Stroncek D; Verfaillie CM
Blood; 1996 Sep; 88(6):2033-42. PubMed ID: 8822922
[TBL] [Abstract][Full Text] [Related]
19. Transplantation of highly purified CD34+Thy-1+ hematopoietic stem cells in patients with recurrent indolent non-Hodgkin's lymphoma.
Vose JM; Bierman PJ; Lynch JC; Atkinson K; Juttner C; Hanania CE; Bociek G; Armitage JO
Biol Blood Marrow Transplant; 2001; 7(12):680-7. PubMed ID: 11787531
[TBL] [Abstract][Full Text] [Related]
20. Tumor-specific aneuploidy not detected in CD19+ B-lymphoid cells from myeloma patients in a multidimensional flow cytometric analysis.
McSweeney PA; Wells DA; Shults KE; Nash RA; Bensinger WI; Buckner CD; Loken MR
Blood; 1996 Jul; 88(2):622-32. PubMed ID: 8695810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
